CCO Highlights of 2024 Hematology Meetings: Focus on Rare Blood Diseases *

Review expert perspectives on the implications of key studies in nonmalignant rare blood diseases presented at various hematology conferences in 2024 via an expert-curated downloadable slideset and an expert-authored ClinicalThought commentary.

Share

Program Content

Activities

CCO Highlights of 2024 Hematology Meetings: Focus on Rare Blood Diseases
CCO Highlights of 2024 Hematology Meetings: Focus on Rare Blood Diseases
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 21, 2024

Expires: August 20, 2025

Faculty

cover img faculity

Guy Young, MD

Director, Hemostasis and Thrombosis Center
Director, Clinical Coagulation Laboratory
Cancer and Blood Disorders Institute
Children’s Hospital Los Angeles
Professor of Pediatrics
Division of Hematology/Oncology
Department of Pediatrics
University of Southern California Keck School of Medicine
Los Angeles, California

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.